1887

Abstract

In this study, the contribution of type I interferons (IFNs) to protection against infection with enterovirus 71 (EV71) was investigated using a murine model where the virus was administrated to neonatal Institute of Cancer Research (ICR) mice by either the intraperitoneal (i.p.) or the oral route. In i.p. inoculated mice, post-infection treatment of dexamethasone (5 mg kg at 2 or 3 days after infection) exacerbated clinical symptoms and increased the tissue viral titre. In contrast, polyriboinosinic : polyribocytidylic acid [poly(I : C); 10 or 100 μg per mouse at 12 h before infection], a potent IFN inducer, improved the survival rate and decreased the tissue viral titres after EV71 challenge, which correlated with an increase in serum IFN- concentration, the percentage of dendritic cells, their expression of major histocompatibility complex class II molecule and IFN- in spleen. Treatment with a neutralizing antibody for type I IFNs (10 neutralizing units per mouse, 6 h before and 12 h after infection) resulted in frequent deaths and higher tissue viral load in infected mice compared with control mice. In contrast, an early administration of recombinant mouse IFN-A (10 U per mouse for 3 days starting at 0, 1 or 3 days after infection) protected the mice against EV71 infection. analysis of virus-induced death in three human cell lines showed that human type I IFNs exerted a direct protective effect on EV71. It was concluded that type I IFNs play an important role in controlling EV71 infection and replication.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81195-0
2005-12-01
2019-11-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/12/3263.html?itemId=/content/journal/jgv/10.1099/vir.0.81195-0&mimeType=html&fmt=ahah

References

  1. Chang, L.-Y., Lin, T.-Y., Hsu, K.-H. & 8 other authors ( 1999; ). Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354, 1682–1686.[CrossRef]
    [Google Scholar]
  2. Chang, L.-Y., Hsia, S.-H., Wu, C.-T., Huang, Y.-C., Lin, K.-L., Fang, T.-Y. & Lin, T.-Y. ( 2004; ). Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002. Pediatr Infect Dis J 23, 327–332.[CrossRef]
    [Google Scholar]
  3. Chaudhuri, A. ( 2004; ). Adjunctive dexamethasone treatment in acute bacterial meningitis. Lancet Neurol 3, 54–62.[CrossRef]
    [Google Scholar]
  4. Goodbourn, S., Didcock, L. & Randall, R. E. ( 2000; ). Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81, 2341–2364.
    [Google Scholar]
  5. Guggenheim, M. A. & Baron, S. ( 1977; ). Clinical studies of an interferon inducer, polyriboinosinic-polyribocytidylic acid [poly(I)-poly(C)], in children. J Infect Dis 136, 50–58.[CrossRef]
    [Google Scholar]
  6. Ho, M., Chen, E.-R., Hsu, K.-H., Twu, S.-J., Chen, K.-T., Tsai, S.-F., Wang, J.-R. & Shih, S.-R. ( 1999; ). An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 341, 929–935.[CrossRef]
    [Google Scholar]
  7. Hsiung, G. D. ( 1994; ). Virus assay, neutralization test and antiviral assay. In Hsiung's Diagnostic Virology, pp. 46–55. Edited by G. D. Hsiung, C. K. Y. Fong & M. L. Landry. New Haven: Yale University Press.
  8. Huang, C.-C., Liu, C.-C., Chang, Y.-C., Chen, C.-Y., Wang, S.-T. & Yeh, T.-F. ( 1999; ). Neurologic complications in children with enterovirus 71 infection. N Engl J Med 341, 936–942.[CrossRef]
    [Google Scholar]
  9. Kirkwood, J. ( 2002; ). Cancer immunotherapy: the interferon-alpha experience. Semin Oncol 29, 18–26.[CrossRef]
    [Google Scholar]
  10. Komatsu, H., Shimizu, Y., Takeuchi, Y., Ishiko, H. & Takada, H. ( 1999; ). Outbreak of severe neurologic involvement associated with enterovirus 71 infection. Pediatr Neurol 20, 17–23.[CrossRef]
    [Google Scholar]
  11. Kunzmann, V., Kretzschmar, E., Herrmann, T. & Wilhelm, M. ( 2004; ). Polyinosinic-polycytidylic acid-mediated stimulation of human γδT cells via CD11c dendritic cell-derived type I interferons. Immunology 112, 369–377.[CrossRef]
    [Google Scholar]
  12. Lin, T.-Y., Chang, L.-Y., Hsia, S.-H., Huang, Y.-C., Chiu, C.-H., Hsueh, C., Shih, S.-R., Liu, C. C. & Wu, M.-H. ( 2002a; ). The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis 34, S52–S57.[CrossRef]
    [Google Scholar]
  13. Lin, T.-Y., Chang, L.-Y., Huang, Y.-C., Hsu, K.-H., Chiu, C.-H. & Yang, K.-D. ( 2002b; ). Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr 91, 632–635.[CrossRef]
    [Google Scholar]
  14. Lin, T.-Y., Hsia, S.-H., Huang, Y.-C., Wu, C.-T. & Chang, L.-Y. ( 2003; ). Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis 36, 269–274.[CrossRef]
    [Google Scholar]
  15. Lum, L.-C., Wong, K.-T., Lam, S.-K. & 7 other authors ( 1998; ). Fatal enterovirus 71 encephalomyelitis. J Pediatr 133, 795–798.[CrossRef]
    [Google Scholar]
  16. McMinn, P. C. ( 2002; ). An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26, 91–107.[CrossRef]
    [Google Scholar]
  17. Nolan, M. A., Craig, M. E., Lahra, M. M., Rawlinson, W. D., Prager, P. C., Williams, G. D., Bye, A. M. & Andrews, P. I. ( 2003; ). Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology 60, 1651–1656.[CrossRef]
    [Google Scholar]
  18. Padalko, E., Nuyens, D., de Palma, A., Verbeken, E., Aerts, J. L., de Clercq, E., Carmeliet, P. & Neyts, J. ( 2004; ). The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis. Antimicrob Agents Chemother 48, 267–274.[CrossRef]
    [Google Scholar]
  19. Poast, J., Seidel, H. M., Hendricks, M. D., Haslam, J. A., Levy, H. B. & Baron, S. ( 2002; ). Poly I:CLC induction of the interferon system in mice: an initial study of four detection methods. J Interferon Cytokine Res 22, 1035–1040.[CrossRef]
    [Google Scholar]
  20. Pyo, S., Gangemi, J. D., Ghaffar, A. & Mayer, E. P. ( 1993; ). Poly I:C-induced antiviral and cytotoxic activities are mediated by different mechanisms. Int J Immunopharmacol 15, 477–486.[CrossRef]
    [Google Scholar]
  21. Sasaki, O., Karaki, T. & Imanishi, J. ( 1986; ). Protective effect of interferon on infections with hand, foot, and mouth disease virus in newborn mice. J Infect Dis 153, 498–502.[CrossRef]
    [Google Scholar]
  22. Schmidt, K. N., Leung, B., Kwong, M., Zarember, K. A., Satyal, S., Navas, T. A., Wang, F. & Godowski, P. J. ( 2004; ). APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol 172, 138–143.[CrossRef]
    [Google Scholar]
  23. Sommer, J. B., Heckmann, J. G., Kraus, J., Neundorfer, B. & Erbguth, F. J. ( 2000; ). Generalized brain edema in non-purulent meningoencephalitis. The anti-edema effect of therapy with dexamethasone. Nervenarzt 71, 112–115.[CrossRef]
    [Google Scholar]
  24. Wang, S.-M., Liu, C.-C., Tseng, H.-W., Wang, J.-R., Huang, C.-C., Chen, Y.-J., Yang, Y.-J., Lin, S.-J. & Yeh, T.-F. ( 1999; ). Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis 29, 184–190.[CrossRef]
    [Google Scholar]
  25. Wang, S.-M., Lei, H.-Y., Huang, K.-J., Wu, J.-M., Wang, J.-R., Yu, C.-K., Su, I.-J. & Liu, C.-C. ( 2003; ). Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis 188, 564–570.[CrossRef]
    [Google Scholar]
  26. Wang, Y.-F., Chou, C.-T., Lei, H.-Y. & 8 other authors ( 2004; ). A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 78, 7916–7924.[CrossRef]
    [Google Scholar]
  27. Wu, C.-K., Lin, Y.-C., Fann, C., Liao, N.-S., Shin, S.-R. & Ho, M.-S. ( 2002; ). Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20, 895–904.
    [Google Scholar]
  28. Yan, J.-J., Wang, J.-R., Liu, C.-C., Yang, H.-B. & Su, I.-J. ( 2000; ). An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J Clin Virol 17, 13–22.[CrossRef]
    [Google Scholar]
  29. Yan, J.-J., Su, I.-J., Chen, P.-F., Liu, C.-C., Yu, C.-K. & Wang, J.-R. ( 2001; ). Complete genome analysis of enterovirus 71 isolated from an outbreak in Taiwan and rapid identification of enterovirus 71 and coxsackievirus A16 by RT-PCR. J Med Virol 65, 331–339.[CrossRef]
    [Google Scholar]
  30. Yang, K.-D., Yang, M.-Y., Li, C.-C., Lin, S.-F., Chong, M.-C., Wang, C.-L., Chen, R.-F. & Lin, T.-Y. ( 2001; ). Altered cellular but not humoral reactions in children with complicated enterovirus 71 infections in Taiwan. J Infect Dis 183, 850–856.[CrossRef]
    [Google Scholar]
  31. Yu, C.-K., Chen, C.-C., Chen, C.-L., Wang, J.-R., Liu, C.-C., Yan, J.-J. & Su, I.-J. ( 2000; ). Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci 7, 523–528.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81195-0
Loading
/content/journal/jgv/10.1099/vir.0.81195-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error